HeartWare Pipeline Update: HVAD On Track For 2012 PMA Approval
This article was originally published in The Gray Sheet
Executive Summary
Firm notes that it has not yet heard from FDA on whether an advisory committee review will be required for its left ventricular assist device, intended as a bridge to transplant.
You may also be interested in...
HeartWare Touts Early Success In U.S. Launch Of HVAD
HeartWare sold 134 HVAD ventricular assist systems in the U.S. following FDA approval in November and continues to rapidly add more centers to its customer base.
HeartWare Gets FDA Panel Date For HVAD Heart Failure Implant
Advisory panel review April 25 could pave the way for PMA approval this year as a bridge to heart transplant.
News In Brief
HeartWare HVAD submission